Skip to main content

and
  1. Article

    Open Access

    Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

    The impact of genetic variability of pharmacogenes as a possible risk factor for adverse drug reactions is elucidated in the EMPAR (Einfluss metabolischer Profile auf die Arzneimitteltherapiesicherheit in der ...

    Jochen Fracowiak, Tatjana Huebner, Steffen Heß in The Pharmacogenomics Journal (2022)

  2. No Access

    Article

    New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease

    The vast majority of the world population is infected with at least one member of the human herpesvirus family. Herpes simplex virus (HSV) infections are the cause of cold sores and genital herpes as well as l...

    Gerald Kleymann, Rüdiger Fischer, Ulrich A.K. Betz, Martin Hendrix in Nature Medicine (2002)